Halis Süleyman
Impact in
- Pharmacology top 0.2%
- Inflammatory mediators and NSAID effects
- Pharmacological Effects of Natural Compounds
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Chemotherapy-induced organ toxicity mitigation 28
- Cardiac Ischemia and Reperfusion 23
- Co-authors
- Zekai Halıcı (46 shared papers)Fehmi Odabaşoğlu (21 shared papers)Elif Çadırcı (31 shared papers)Yasin Bayır (18 shared papers)Mesut Halici (11 shared papers)Yalçın Karagöz (6 shared papers)Alı Aslan (9 shared papers)Berna Demircan (5 shared papers)
- Journals
- EXPERIMENTAL ANIMALS (11 papers)Advances in Clinical and Experimental Medicine (8 papers)Biological and Pharmaceutical Bulletin (6 papers)Pharmacological Reports (5 papers)Phytomedicine (5 papers)
- Partner nations
- TürkiyeUnited StatesAzerbaijan
In The Last Decade
Halis Süleyman
279 papers receiving 5.3k citations
Peers
Comparison fields: 5 of 136
- Pharmacology 849
- Complementary and alternative medicine 660
- Biochemistry 351
- Biochemistry 383
- Pharmacology 728
Countries citing papers authored by Halis Süleyman
This map shows the geographic impact of Halis Süleyman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halis Süleyman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halis Süleyman more than expected).
Fields of papers citing papers by Halis Süleyman
This network shows the impact of papers produced by Halis Süleyman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halis Süleyman. The network helps show where Halis Süleyman may publish in the future.
Co-authors
The 25 scholars most cited alongside Halis Süleyman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 305 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anti-inflammatory and side effects of cyclooxygenase inhibitors. | 2008 | 270 |
| 2 | 2005 | 241 | |
| 3 | 2010 | 173 | |
| 4 | 2004 | 143 | |
| 5 | 2005 | 135 | |
| 6 | 2007 | 127 | |
| 7 | 1999 | 122 | |
| 8 | 2005 | 107 | |
| 9 | 2013 | 106 | |
| 10 | 2007 | 102 | |
| 11 | 2005 | 101 | |
| 12 | 2002 | 90 | |
| 13 | 2007 | 82 | |
| 14 | 2008 | 82 | |
| 15 | 2011 | 82 | |
| 16 | 2002 | 81 | |
| 17 | 2008 | 77 | |
| 18 | 2008 | 77 | |
| 19 | 2010 | 73 | |
| 20 | 2005 | 73 |
About Halis Süleyman
Halis Süleyman is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Pharmacology, Physiology and Surgery, having authored 305 papers that have together received 5.7k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (29 papers), Chemotherapy-induced organ toxicity mitigation (28 papers), Alcoholism and Thiamine Deficiency (24 papers), Inflammatory mediators and NSAID effects (24 papers), Cardiac Ischemia and Reperfusion (23 papers), Helicobacter pylori-related gastroenterology studies (17 papers), Neuroscience and Neuropharmacology Research (14 papers) and Nitric Oxide and Endothelin Effects (13 papers). The work is most often cited by research in Pharmacology (849 citations), Complementary and alternative medicine (660 citations), Biochemistry (351 citations), Biochemistry (383 citations) and Pharmacology (728 citations). Halis Süleyman has collaborated with scholars based in Türkiye, United States and Azerbaijan. Frequent co-authors include Zekai Halıcı, Fehmi Odabaşoğlu, Elif Çadırcı, Yasin Bayır, Mesut Halici, Yalçın Karagöz, Alı Aslan, Berna Demircan, Fatih Akçay and Akçahan Gepdíremen. Their work appears in journals such as EXPERIMENTAL ANIMALS, Advances in Clinical and Experimental Medicine, Biological and Pharmaceutical Bulletin, Pharmacological Reports and Phytomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.